Home Industry News Following Merger with East Coast Firm, Biotech Firm Decides to Locate HQ in Seattle
Industry NewsLife Science

Following Merger with East Coast Firm, Biotech Firm Decides to Locate HQ in Seattle

Share
Share

By The Registry Staff Clay Siegall, the co-founder and former CEO of Bothell-based biotech Seagen, is currently leading a new biotech venture through a merger. In March, Siegall was appointed as the CEO of Morphimmune, which recently announced its merger with Immunome, a biotech company based in Exton, Pennsylvania (Nasdaq: IMNM). Following the merger, Siegall […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

2026 Pacific Northwest CRE Rising Stars

PNW CRE Rising Stars

Featured Posts


Recent Posts

Related Articles

Quarterra Plans 300-Unit Apartment Project at Former FOX 13 Site in Seattle’s South Lake Union

Seattle's most storied piece of Westlake Avenue real estate is headed toward...

BNBuilders, Miller Hull Break Ground on $37MM Snohomish Fire Stations

Construction has begun on replacement stations in Monroe and Lake Stevens roughly...

Starbird Chicken Signs 17-Unit Washington Franchise Deal with Former Jack in the Box Operator

A San Francisco-born fast casual chicken concept is following a proven multi-unit...